Alliance Pharma PLC has announced its total voting rights as of 30 November 2023. The company's issued share capital consists of 540,390,080 Ordinary Shares of 1p each, and the total number of voting rights in the company is also 540,390,080. Shareholders can use this figure as the denominator for calculating their interest in the company under the FCA's Disclosure Guidance and Transparency Rules. Alliance Pharma is a growing consumer healthcare company that aims to empower people to make a positive difference to their health and wellbeing by making trusted and proven brands available worldwide. The company achieves organic growth through investing in priority brands and channels, innovation, and selective geographic expansion. It may also consider complementary acquisitions to enhance its organic growth.